EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association

Barbara Kneis, Stefan Wirtz, Klaus Weber, Axel Denz iD, Matthias Gittler, Carol Geppert, Maximilian Brunner, Christian Krautz iD, Alexander Reinhard Siebenhüner iD, Robert Schierwagen, Olaf Tyc iD, Abbas Agaimy iD und 4 weitere

International Journal of Molecular Sciences · 07.02.2023 · 24 (4) · 3265

DOI: 10.3390/ijms24043265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.02.2023. Verfasst von Barbara Kneis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Hospital Erlangen, 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: Colonic Neoplasms, Rectal Neoplasms, Gastrointestinal Microbiome. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tumorzentrum Erlangen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the current era of precision oncology, it is widely acknowledged that CRC is a heterogeneous disease entity. Tumor location (right- or left-sided colon cancer or rectal cancer) is a crucial factor in determining disease progression as well as prognosis and influences disease management. In the last decade, numerous works have reported that the microbiome is an important element of CRC carcinogenesis, progression and therapy response. Owing to the heterogeneous nature of microbiomes, the findings of these studies were inconsistent. The majority of the studies combined colon cancer (CC) and rectal cancer (RC) samples as CRC for analysis. Furthermore, the small intestine, as the major site for immune surveillance in the gut, is understudied compared to the colon. Thus, the CRC heterogeneity puzzle is far from being solved, and more research is necessary for prospective trials that separately investigate CC and RC. Our prospective study aimed to map the colon cancer landscape using 16S rRNA amplicon sequencing in biopsy samples from the terminal ileum, healthy colon tissue, healthy rectal tissue and tumor tissue as well as in preoperative and postoperative stool samples of 41 patients. While fecal samples provide a good approximation of the average gut microbiome composition, mucosal biopsies allow for detecting subtle variations in local microbial communities. In particular, the small bowel microbiome has remained poorly characterized, mainly because of sampling difficulties. Our analysis revealed the following: (i) right- and left-sided colon cancers harbor distinct and diverse microbiomes, (ii) the tumor microbiome leads to a more consistent cancer-defined microbiome between locations and reveals a tumor microbiome–ileal microbiome association, (iii) the stool only partly reflects the microbiome landscape in patients with CC, and (iv) mechanical bowel preparation and perioperative antibiotics together with surgery result in major changes in the stool microbiome, characterized by a significant increase in the abundance of potentially pathogenic bacteria, such as Enterococcus. Collectively, our results provide new and valuable insights into the complex microbiome landscape in patients with colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsRectal NeoplasmsGastrointestinal MicrobiomeHumansProspective StudiesRNA, Ribosomal, 16SPrecision MedicineColonIleum

Stichwörter der Autor:innen

colon cancergut microbiomeleft-sided colon cancermicrobiomeright-sided colon cancertumor microbiome

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Nephrology, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Department of Internal Medicine I, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Institute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Department of Gastroenterology and Hepatology, University Hospital Zurich and University Zurich, 8091 Zürich, Switzerland.
  • Department of Internal Medicine B, University Hospital Münster, 48149 Münster, Germany.

ORCID-Profile: Axel Denz, Christian Krautz, Alexander Reinhard Siebenhüner, Olaf Tyc, Abbas Agaimy, Jonel Trebicka, Stephan Kersting, Melanie Langheinrich

Förderung

  • Tumorzentrum Erlangen

Zitieren

APA

Kneis, B., Wirtz, S., Weber, K., Denz, A., Gittler, M., Geppert, C., Brunner, M., Krautz, C., Siebenhüner, A. R., Schierwagen, R., Tyc, O., Agaimy, A., Grützmann, R., Trebicka, J., Kersting, S., & Langheinrich, M. (2023). Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association. International Journal of Molecular Sciences, 24(4), 3265. https://doi.org/10.3390/ijms24043265

Vancouver

Kneis B, Wirtz S, Weber K, Denz A, Gittler M, Geppert C, et al. Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association. International Journal of Molecular Sciences. 2023;24(4):3265. doi:10.3390/ijms24043265

BibTeX
@article{Kneis2023,
  author = {Kneis, Barbara and Wirtz, Stefan and Weber, Klaus and Denz, Axel and Gittler, Matthias and Geppert, Carol and Brunner, Maximilian and Krautz, Christian and Siebenhüner, Alexander Reinhard and Schierwagen, Robert and Tyc, Olaf and Agaimy, Abbas and Grützmann, Robert and Trebicka, Jonel and Kersting, Stephan and Langheinrich, Melanie},
  title = {Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3265},
  doi = {10.3390/ijms24043265}
}
Kostenlos starten →